(Reuters) – Modern Inc. received a report from the California Department of Health on Tuesday that several people were treated at a center in San Diego for possible allergic reactions to its COVID-19 vaccine from a particular batch Was.
A statement was released on Sunday following a comment by the company’s top epidemiologist in California recommending providers to stop too many vaccinations. 41L20A which are under investigation due to possible allergic reactions.
The epidemic said in a statement here, “A higher-than-normal number was reported in a community immunization clinic with a very high number of specific modern morden vaccines. At least 10 individuals were diagnosed within a 24-hour period. Requires medical attention, ”Pandemic said in a statement here. .
The vaccine manufacturer stated that it was unaware of comparable cases of adverse events from other vaccination centers, which may have led to the vaccine being administered from the same lot or other lots.
A lot of storage has a total of 307,300 doses, Modern said, totaling 1,272,200 doses that were produced in batches.
Modern said it was working closely with US health regulators to understand the cases and whether the use of the lot was withheld.
Modern said that many a million doses have been distributed to about 1,700 vaccination sites in 37 states. (bit.ly/39MPtlF)
Reporting by Manojna Maddipatla in Bengaluru; Editing by Vinay Dwivedi and Shinjini Ganguly